FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients

U.S. Food and Drug Administration (FDA) review found that fluoroquinolone antibiotics can increase the occurrence of rare but serious events of ruptures or tears in the main artery of the body, called the aorta. These tears, called aortic dissections, or ruptures of an aortic aneurysm can lead to dangerous bleeding...

Quelle:

Fluorchinolone
Veröffentlicht am 27/07/2016

Fluorchinolone sind eine Subgruppe der Chinolone. Die Substanzen werden antibiotisch eingesetzt und gehören zu den Gyrasehemmern. Sie zeichnen sich durch ein breites Wirkungsspektrum aus. Sie werden in der Humanmedizin und der Veterinärmedizin eingesetzt.

27.07.2016 FDA-Warnung: langfristige Nervenschäden und gerissene Sehnen

Liste

Ciprofloxacin
Enoxacin
Finafloxacin (Xtoro)...

Quelle:

FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects

The U.S. Food and Drug Administration (FDA) approved changes to the labels of fluoroquinolone antibacterial drugs for systemic use (i.e., taken by mouth or by injection). These medicines are associated with disabling and potentially permanent side effects of the tendons, muscles, joints, nerves, and...

Quelle:

FDA approves safety labeling changes for fluoroquinolones

Today, the FDA has approved labeling changes for antibacterial drugs called fluoroquinolones, including an updated Boxed Warning, and advising that the serious side effects associated with fluoroquinolones generally outweigh the benefits for patients with acute bacterial sinusitis (ABS), acute bacterial exacerbation of chronic bronchitis (ABECB) and uncomplicated urinary...

Quelle:

FDA Drug Safety Podcast: FDA requires label changes to warn of risk for possibly permanent nerve damage from antibacterial fluoroquinolone drugs taken by mouth or by injection

Narrator: Welcome to the FDA Drug Safety Podcast for Healthcare Professionals from the Division of Drug Information. Today’s topic: FDA requires label changes to warn of risk for possibly permanent nerve damage from antibacterial fluoroquinolone drugs taken by...